The aim of this study was to determine whether CSF concentrations of beta-amyloid peptides and tau protein differ between women with PE and women with HELLP syndrome as compared to healthy pregnant women during the third trimester of pregnancy. The gene discussed is MAPT; the disease is HELLP syndrome.